Abstract:Objectives:To explore the characteristics of lipid metabolism of malignantly transformed macrophages (tMΦ) in the microenvironment of glioma stem cells (GSCs) and the underlying regulatory mechanisms and to provide experimental basis for precision treatment against tMΦ.Methods:In this study, we used macrophages (MΦ) and tMΦ cell lines (including tMΦ 1 and tMΦ 2), and analyzed the lipid metabolism characteristics of tMΦ by detecting the levels of triacylglycerol (TG) and total cholesterol (TC) in the cells. Western blot experiments were performed to detect the expression levels of key molecules regulating lipid metabolism including calmodulin (CaM), apolipoprotein E (ApoE), hormone-sensitive triacylglycerol lipase (HSL), and liver X receptor (LXR). We then constructed the differentially expressed long non-coding RNA (lncRNA) expression profile of tMΦ, chose HOXC-AS3 (homeobox C cluster antisense RNA3) as the research object, and established HOXC-AS3 over-expression and low-expression tMΦ cell lines. Real-time quantitative PCR (qRT-PCR) was used to detect the expression level of CaM in tMΦ after HOXC-AS3 was up-regulated and silenced. The colony forming ability of tMΦ after the silencing of HOXC-AS3 was observed through the colony formation experiment, the invasion ability was detected by the Transwell experiment, and the tumorigenic ability was observed by establishing an in vivo xenograft tumor mouse model. Proteomic analysis of the binding protein related to the lipid metabolism of HOXC-AS3 was performed, and RNA immunoprecipitation was used to verify whether the two could form a complex, and the regulation of HOXC-AS3 to its binding protein was analyzed by qRT-PCR and Western blot experiments. Results:The content of TC and TG and the expression levels of CaM, ApoE, HSL, and LXR proteins were higher in tMΦ than in normal MΦ (all P<0.01). LncRNA expression profile results suggested that compared with normal MΦ, HOXC-AS3 was highly expressed in tMΦ 1 and tMΦ 2. The results of colony formation assay showed that the number of clones of tMΦ 1 and tMΦ 2 after silencing HOXC-AS3(sh-HOXC-AS3 group) was significantly less than that of the blank control group (sh-NC group) (all P<0.01). Transwell experiment results showed that the number of transmembrane cells in the sh-HOXC-AS3 group tMΦ 1 and tMΦ 2 was less than that in the sh-NC group (both P<0.01). The tumorigenicity experiment results showed that the transplanted tumor volume of mice in the sh-HOXC-AS3 group was smaller than sh -NC group (both P<0.01). The results of qRT-PCR indicated that overexpression of HOXC-AS3 could up-regulate the expression of CaM in tMΦ, while silencing HOXC-AS3 could down-regulate the expression of CaM in tMΦ (both P<0.01). The proteomic analysis results indicated that the lipid metabolism-related protein with the highest correlation with HOXC-AS3 was hnRNPA1. The results of RNA immunoprecipitation confirmed that hnRNPA1 and HOXC-AS3 could form a complex. After hnRNPA1 was silenced, the expression of CaM in tMΦ was down-regulated (both P< 0.01), and after silencing HOXC-AS3 in tMΦ, the changes of hnRNPA1 gene and protein levels were not statistically significant (all P>0.05). Conclusions:The level of lipid metabolism and synthesis in tMΦ is higher than that in normal MΦ, and the mechanism may be that HOXC-AS3 binds to hnRNPA1 to affect the expression of lipid metabolism molecule CaM, thereby regulating the lipid metabolism remodeling of tMΦ. Targeting HOXC-AS3 can inhibit the proliferation and invasion of tMΦ in the microenvironment of GSCs. HOXC-AS3 may be a potential target for improving the immunotherapy effect of glioma.

miR-223-3p regulates the malignant transformation of macrophages in the glioma microenvironment by targeting RIPK3

MiR-223-3p Overexpression Inhibits Cell Proliferation and Migration by Regulating Inflammation-Associated Cytokines in Glioblastomas.

Microrna-138 Modulates Glioma Cell Growth, Apoptosis And Invasion Through The Suppression Of The Akt/Mtor Signalling Pathway By Targeting Creb1

MicroRNA‑218 Inhibits the Malignant Phenotypes of Glioma by Modulating the TNC/AKT/AP‑1/TGFβ1 Feedback Signaling Loop

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

MiR-330-mediated Regulation of SH3GL2 Expression Enhances Malignant Behaviors of Glioblastoma Stem Cells by Activating ERK and PI3K/AKT Signaling Pathways.

miR-193a-3p Promotes the Invasion, Migration, and Mesenchymal Transition in Glioma through Regulating BTRC

STAT3 Signaling Pathway Regulates Glioma Stem Cells Induced Host Macrophage Malignance

MiR-302c-3p Suppresses Invasion and Proliferation of Glioma Cells Via Down-Regulating Metadherin (MTDH) Expression.

The Role of miR-223 on PAX6 Gene 3′-Untranslated Region in Glioblastoma Cells

Microrna-223 Promotes the Growth and Invasion of Glioblastoma Cells by Targeting Tumor Suppressor PAX6.

Exosomal Mir-221 Targets DNM3 to Induce Tumor Progression and Temozolomide Resistance in Glioma

TGF-â1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells.

MicroRNA-338-5p Plays a Tumor Suppressor Role in Glioma Through Inhibition of the MAPK-signaling Pathway by Binding to FOXD1

TGF-β1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells

microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma.

MicroRNA-375 Inhibits Glioma Cell Proliferation and Migration by Downregulating RWDD3 Inï¿½vitro

Molecular mechanism of long non-coding RNA HOXC-AS3 in regulating lipid metabolism of malignantly transformed macrophages in the microenvironment of glioma stem cells

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-Mobility Group Nucleosome-Binding Domain 5.

MicroRNA-375 Inhibits Glioma Cell Proliferation and Migration by Downregulating RWDD3 in Vitro.